1. Report Industry Investment Rating - The report maintains an overall optimistic view of the North Exchange market for the whole year, believing that the positioning and development direction of the "specialized, refined, characteristic, and innovative" North Exchange market are highly consistent with the national policy orientation of the "self - controllable" and innovation - driven development strategy [24]. 2. Core Viewpoints of the Report - In July 2025, the North - 50 Index and the North Specialized, Refined, Characteristic, and Innovative Index underperformed major indices such as the ChiNext and STAR Market. However, in the first seven months of 2025, the North - 50 Index rose 37%, outperforming other major indices. The market was weak in July, but some sub - sectors like building decoration and pharmaceutical biology performed well. The market has been in a range - bound consolidation for over two months, and with continuous progress in "high - quality" expansion, code switching of existing stocks, and the issuance of specialized, refined, characteristic, and innovative index funds, the market should gradually turn optimistic. The market may return to the performance - driven mainline, and attention should be paid to high - quality companies with continuous high - growth performance [3][6][24]. 3. Summary by Relevant Catalogs 3.1 Week - view - In July 2025, the North - 50 Index fell 1.68%, and the North Specialized, Refined, Characteristic, and Innovative Index fell 2.70%, underperforming major indices. In the first seven months of 2025, the North - 50 Index rose 37%, far outperforming other major indices, and indices such as the STAR - 200 and CSI 2000 also rose over 20%. In July, sectors such as building decoration and pharmaceutical biology in the North Exchange market had relatively high increases. Only 16 companies had a monthly increase of over 20%, and 6 companies including Hengli Drilling Tools had an increase of over 50%. Compared with June 2025, trading volume, turnover, and turnover rate in July all declined. As of July 31, 2025, the overall price - to - earnings ratio (TTM, excluding negatives) of the North Exchange A - share index reached 51 times, 134% of the ChiNext index and 84% of the STAR Market index [3][6][12]. 3.2 Market Performance - This week, the overall price - to - earnings ratios of the ChiNext, STAR Market, and North Exchange A - shares declined. The North Exchange A - shares' overall PE dropped from 52.17X to 50.92X. In terms of liquidity, the daily average trading volume of North Exchange A - shares this week was 257 billion yuan, a 17% decrease from last week. The daily average turnover rate of North Exchange A - shares dropped to 5.94%, a decrease of 1.1 percentage points from last week. The North - 50 Index fell 2.70% this week, and major indices such as the CSI 300, STAR - 50, and ChiNext also declined [26][27]. 3.3 New Stock Listings - From January 1, 2024, to August 1, 2025, 30 new companies were listed on the North Exchange. From July 28 to August 1, 2025, 1 new company, Dingjia Precision, was listed. From January 1, 2023, to August 1, 2025, the average issue price - to - earnings ratio of 107 listed companies was 16.20X, and the median was 15.86X. The average first - day increase was 111%, and the median was 51% [32][35]. 3.4 New Stock IPOs - From July 28 to August 1, 2025, 2 companies, Aomisen and Sanxie Electric, updated their review status to registration; 1 company, Yangtze River Energy Technology, updated its status to passing the listing committee meeting; 22 companies updated their status to being under inquiry. Next week, the North Exchange will review the IPO applications of 2 companies, Zhongcheng Consulting and Nante Technology [41].

Market Performance - In July, the A-share market experienced an overall upward trend, with the Shanghai Composite Index rising by 3.74%, the Shenzhen Component Index increasing by 5.20%, and the ChiNext Index gaining 8.14% by the end of July [1] Top Performing Stocks - The top-performing stock in July was Shangwei New Materials, which saw a staggering increase of 1083.42%, making it the first stock in A-shares to achieve a tenfold increase since 2025 [3][6] - Guangshengtang ranked second with a monthly increase of 218.94%, driven by significant progress in its hepatitis B innovative drug development [3][7] - Hengli Drilling Tools achieved a monthly increase of 191.24%, boosted by the commencement of a major hydropower project in the Yarlung Tsangpo River basin [3][9] Individual Stock Highlights - **Shangwei New Materials**: The stock price surged from 9.34 yuan to 92.07 yuan between July 9 and July 30, with 11 trading days experiencing a 20% limit up. The surge was attributed to an announcement regarding a significant acquisition that would change its controlling shareholder [6] - **Guangshengtang**: The company received ethical review approval for its phase III clinical trial of GST-HG141 and had another drug, GST-HG131, recognized as a breakthrough therapy by the National Medical Products Administration [7][8] - **Hengli Drilling Tools**: The company specializes in manufacturing various engineering drilling tools and benefited from the positive sentiment surrounding the hydropower sector following the announcement of a large-scale project [9]

Market Overview - In July, the A-share market experienced an overall upward trend, with the Shanghai Composite Index rising by 3.74%, the Shenzhen Component Index increasing by 5.20%, and the ChiNext Index gaining 8.14% by the end of July [1] Top Performing Stocks - The top-performing stock in July was Shangwei New Materials, which saw a staggering increase of 1083.42%, making it the first stock to achieve a tenfold increase in A-shares since 2025 [3][6] - Guangshengtang ranked second with a monthly increase of 218.94%, driven by significant progress in its hepatitis B innovative drug development [3][7] - Hengli Drilling Tools achieved a monthly increase of 191.24%, boosted by the commencement of a major hydropower project in the Yarlung Tsangpo River basin [3][9] Detailed Stock Performance - **Shangwei New Materials**: - The stock price surged from 9.34 yuan to 92.07 yuan between July 9 and July 30, with 11 trading days experiencing a 20% limit up [6] - The surge was attributed to an announcement regarding a significant acquisition that would change the controlling shareholder [6] - The company reported a net profit of 88.68 million yuan for 2024, a year-on-year increase of 25.01% [6] - **Guangshengtang**: - The stock had two trading days with a 20% limit up, with a total increase of 218.94% for the month [7] - The company received ethical review approval for its phase III clinical trial of GST-HG141 and had another drug, GST-HG131, recognized as a breakthrough therapy [7][8] - Guangshengtang has been a key player in the antiviral and liver disease sectors for over 20 years [8] - **Hengli Drilling Tools**: - The stock experienced three trading days with a 30% limit up, culminating in a 191.24% increase for the month [9] - The rise was linked to the launch of a significant hydropower project with an investment of approximately 1.2 trillion yuan [9] - Hengli specializes in the research, manufacturing, and sales of various drilling tools for construction projects [9]

Core Viewpoint - The recent surge in the stock market is driven by significant gains in specific sectors, particularly in engineering machinery, supported by government investment in water conservancy projects [1][4]. Group 1: Stock Market Performance - The three major stock indices collectively rose, with the Shanghai Composite Index increasing by 1.67% to close at 3593.66 points, the Shenzhen Component Index rising by 2.33% to 11168.14 points, and the ChiNext Index gaining 2.76% to 2340.06 points [1]. - Approximately 71% of stocks experienced gains during the week, with 176 stocks rising over 15% and 10 stocks declining more than 15% [1]. Group 2: Leading Stocks - Hengli Drilling Tools (836942.BJ) topped the weekly gainers with a remarkable 184.05% increase, followed by Upwind New Materials (688585.SH) with a 97.37% rise [1]. - Hengli Drilling Tools achieved a four-day consecutive limit-up, reaching a historical high of 55.93 yuan per share, with a total market capitalization of 3.4 billion yuan [1][4]. Group 3: Industry Insights - The company specializes in the design, production, and sales of various engineering rock-breaking tools, with major clients including China Railway, China Power Construction, and China Communications Construction [4]. - The recent announcement of over 300 billion yuan in support for major water conservancy projects is expected to drive demand for engineering machinery, particularly in the context of infrastructure investment [4][5]. - Analysts predict that the engineering machinery sector will benefit from increased demand as domestic water conservancy projects progress, potentially leading to a dual boost in performance and valuation for the sector [7]. Group 4: Performance and Financials - Hengli Drilling Tools reported a first-quarter revenue of 39.41 million yuan, a year-on-year decrease of 9.02%, while net profit attributable to shareholders increased by 160% to 12.61 million yuan [6]. - The company has issued warnings regarding its stock price volatility, indicating that there have been no significant changes in its fundamentals or undisclosed major information [5]. Group 5: Declining Stocks - Forest Packaging (605500.SH) led the decliners with a 25% drop, attributed to the competitive landscape in the takeaway market and its limited involvement in food packaging [9][10]. - The company anticipates a significant decline in net profit for the first half of 2025, projecting a decrease of 58.64% to 72.42% year-on-year [11].